Vaccine Conjugates Market 2028 by Disease Indication, Type, Patient Stage, Pathogen Type and Geography | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vaccine Conjugates Market - By Disease Indication
1.3.2 Vaccine Conjugates Market - By Type
1.3.3 Vaccine Conjugates Market - By Patient Stage
1.3.4 Vaccine Conjugates Market - By Pathogen Type
1.3.5 Vaccine Conjugates Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. VACCINE CONJUGATES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. VACCINE CONJUGATES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. VACCINE CONJUGATES MARKET - GLOBAL MARKET ANALYSIS
6.1. VACCINE CONJUGATES - GLOBAL MARKET OVERVIEW
6.2. VACCINE CONJUGATES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. VACCINE CONJUGATES MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
7.1. OVERVIEW
7.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
7.3. PNEUMOCOCCAL
7.3.1. Overview
7.3.2. Pneumococcal Market Forecast and Analysis
7.4. INFLUENZA
7.4.1. Overview
7.4.2. Influenza Market Forecast and Analysis
7.5. DIPHTHERIA TETANUS PERTUSSIS
7.5.1. Overview
7.5.2. Diphtheria Tetanus Pertussis Market Forecast and Analysis
7.6. MENINGOCOCCAL
7.6.1. Overview
7.6.2. Meningococcal Market Forecast and Analysis
8. VACCINE CONJUGATES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. MONOVALENT
8.3.1. Overview
8.3.2. Monovalent Market Forecast and Analysis
8.4. MULTIVALENT
8.4.1. Overview
8.4.2. Multivalent Market Forecast and Analysis
9. VACCINE CONJUGATES MARKET - REVENUE AND FORECASTS TO 2028 - PATIENT STAGE
9.1. OVERVIEW
9.2. PATIENT STAGE MARKET FORECASTS AND ANALYSIS
9.3. PEDIATRICS
9.3.1. Overview
9.3.2. Pediatrics Market Forecast and Analysis
9.4. ADULTS
9.4.1. Overview
9.4.2. Adults Market Forecast and Analysis
10. VACCINE CONJUGATES MARKET - REVENUE AND FORECASTS TO 2028 - PATHOGEN TYPE
10.1. OVERVIEW
10.2. PATHOGEN TYPE MARKET FORECASTS AND ANALYSIS
10.3. BACTERIAL
10.3.1. Overview
10.3.2. Bacterial Market Forecast and Analysis
10.4. VIRAL
10.4.1. Overview
10.4.2. Viral Market Forecast and Analysis
10.5. COMBINATION
10.5.1. Overview
10.5.2. Combination Market Forecast and Analysis

11. VACCINE CONJUGATES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Vaccine Conjugates Market Overview
11.1.2 North America Vaccine Conjugates Market Forecasts and Analysis
11.1.3 North America Vaccine Conjugates Market Forecasts and Analysis - By Disease Indication
11.1.4 North America Vaccine Conjugates Market Forecasts and Analysis - By Type
11.1.5 North America Vaccine Conjugates Market Forecasts and Analysis - By Patient Stage
11.1.6 North America Vaccine Conjugates Market Forecasts and Analysis - By Pathogen Type
11.1.7 North America Vaccine Conjugates Market Forecasts and Analysis - By Countries
11.1.7.1 United States Vaccine Conjugates Market
11.1.7.1.1 United States Vaccine Conjugates Market by Disease Indication
11.1.7.1.2 United States Vaccine Conjugates Market by Type
11.1.7.1.3 United States Vaccine Conjugates Market by Patient Stage
11.1.7.1.4 United States Vaccine Conjugates Market by Pathogen Type
11.1.7.2 Canada Vaccine Conjugates Market
11.1.7.2.1 Canada Vaccine Conjugates Market by Disease Indication
11.1.7.2.2 Canada Vaccine Conjugates Market by Type
11.1.7.2.3 Canada Vaccine Conjugates Market by Patient Stage
11.1.7.2.4 Canada Vaccine Conjugates Market by Pathogen Type
11.1.7.3 Mexico Vaccine Conjugates Market
11.1.7.3.1 Mexico Vaccine Conjugates Market by Disease Indication
11.1.7.3.2 Mexico Vaccine Conjugates Market by Type
11.1.7.3.3 Mexico Vaccine Conjugates Market by Patient Stage
11.1.7.3.4 Mexico Vaccine Conjugates Market by Pathogen Type
11.2. EUROPE
11.2.1 Europe Vaccine Conjugates Market Overview
11.2.2 Europe Vaccine Conjugates Market Forecasts and Analysis
11.2.3 Europe Vaccine Conjugates Market Forecasts and Analysis - By Disease Indication
11.2.4 Europe Vaccine Conjugates Market Forecasts and Analysis - By Type
11.2.5 Europe Vaccine Conjugates Market Forecasts and Analysis - By Patient Stage
11.2.6 Europe Vaccine Conjugates Market Forecasts and Analysis - By Pathogen Type
11.2.7 Europe Vaccine Conjugates Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Vaccine Conjugates Market
11.2.7.1.1 Germany Vaccine Conjugates Market by Disease Indication
11.2.7.1.2 Germany Vaccine Conjugates Market by Type
11.2.7.1.3 Germany Vaccine Conjugates Market by Patient Stage
11.2.7.1.4 Germany Vaccine Conjugates Market by Pathogen Type
11.2.7.2 France Vaccine Conjugates Market
11.2.7.2.1 France Vaccine Conjugates Market by Disease Indication
11.2.7.2.2 France Vaccine Conjugates Market by Type
11.2.7.2.3 France Vaccine Conjugates Market by Patient Stage
11.2.7.2.4 France Vaccine Conjugates Market by Pathogen Type
11.2.7.3 Italy Vaccine Conjugates Market
11.2.7.3.1 Italy Vaccine Conjugates Market by Disease Indication
11.2.7.3.2 Italy Vaccine Conjugates Market by Type
11.2.7.3.3 Italy Vaccine Conjugates Market by Patient Stage
11.2.7.3.4 Italy Vaccine Conjugates Market by Pathogen Type
11.2.7.4 Spain Vaccine Conjugates Market
11.2.7.4.1 Spain Vaccine Conjugates Market by Disease Indication
11.2.7.4.2 Spain Vaccine Conjugates Market by Type
11.2.7.4.3 Spain Vaccine Conjugates Market by Patient Stage
11.2.7.4.4 Spain Vaccine Conjugates Market by Pathogen Type
11.2.7.5 United Kingdom Vaccine Conjugates Market
11.2.7.5.1 United Kingdom Vaccine Conjugates Market by Disease Indication
11.2.7.5.2 United Kingdom Vaccine Conjugates Market by Type
11.2.7.5.3 United Kingdom Vaccine Conjugates Market by Patient Stage
11.2.7.5.4 United Kingdom Vaccine Conjugates Market by Pathogen Type
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Vaccine Conjugates Market Overview
11.3.2 Asia-Pacific Vaccine Conjugates Market Forecasts and Analysis
11.3.3 Asia-Pacific Vaccine Conjugates Market Forecasts and Analysis - By Disease Indication
11.3.4 Asia-Pacific Vaccine Conjugates Market Forecasts and Analysis - By Type
11.3.5 Asia-Pacific Vaccine Conjugates Market Forecasts and Analysis - By Patient Stage
11.3.6 Asia-Pacific Vaccine Conjugates Market Forecasts and Analysis - By Pathogen Type
11.3.7 Asia-Pacific Vaccine Conjugates Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Vaccine Conjugates Market
11.3.7.1.1 Australia Vaccine Conjugates Market by Disease Indication
11.3.7.1.2 Australia Vaccine Conjugates Market by Type
11.3.7.1.3 Australia Vaccine Conjugates Market by Patient Stage
11.3.7.1.4 Australia Vaccine Conjugates Market by Pathogen Type
11.3.7.2 China Vaccine Conjugates Market
11.3.7.2.1 China Vaccine Conjugates Market by Disease Indication
11.3.7.2.2 China Vaccine Conjugates Market by Type
11.3.7.2.3 China Vaccine Conjugates Market by Patient Stage
11.3.7.2.4 China Vaccine Conjugates Market by Pathogen Type
11.3.7.3 India Vaccine Conjugates Market
11.3.7.3.1 India Vaccine Conjugates Market by Disease Indication
11.3.7.3.2 India Vaccine Conjugates Market by Type
11.3.7.3.3 India Vaccine Conjugates Market by Patient Stage
11.3.7.3.4 India Vaccine Conjugates Market by Pathogen Type
11.3.7.4 Japan Vaccine Conjugates Market
11.3.7.4.1 Japan Vaccine Conjugates Market by Disease Indication
11.3.7.4.2 Japan Vaccine Conjugates Market by Type
11.3.7.4.3 Japan Vaccine Conjugates Market by Patient Stage
11.3.7.4.4 Japan Vaccine Conjugates Market by Pathogen Type
11.3.7.5 South Korea Vaccine Conjugates Market
11.3.7.5.1 South Korea Vaccine Conjugates Market by Disease Indication
11.3.7.5.2 South Korea Vaccine Conjugates Market by Type
11.3.7.5.3 South Korea Vaccine Conjugates Market by Patient Stage
11.3.7.5.4 South Korea Vaccine Conjugates Market by Pathogen Type
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Vaccine Conjugates Market Overview
11.4.2 Middle East and Africa Vaccine Conjugates Market Forecasts and Analysis
11.4.3 Middle East and Africa Vaccine Conjugates Market Forecasts and Analysis - By Disease Indication
11.4.4 Middle East and Africa Vaccine Conjugates Market Forecasts and Analysis - By Type
11.4.5 Middle East and Africa Vaccine Conjugates Market Forecasts and Analysis - By Patient Stage
11.4.6 Middle East and Africa Vaccine Conjugates Market Forecasts and Analysis - By Pathogen Type
11.4.7 Middle East and Africa Vaccine Conjugates Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Vaccine Conjugates Market
11.4.7.1.1 South Africa Vaccine Conjugates Market by Disease Indication
11.4.7.1.2 South Africa Vaccine Conjugates Market by Type
11.4.7.1.3 South Africa Vaccine Conjugates Market by Patient Stage
11.4.7.1.4 South Africa Vaccine Conjugates Market by Pathogen Type
11.4.7.2 Saudi Arabia Vaccine Conjugates Market
11.4.7.2.1 Saudi Arabia Vaccine Conjugates Market by Disease Indication
11.4.7.2.2 Saudi Arabia Vaccine Conjugates Market by Type
11.4.7.2.3 Saudi Arabia Vaccine Conjugates Market by Patient Stage
11.4.7.2.4 Saudi Arabia Vaccine Conjugates Market by Pathogen Type
11.4.7.3 U.A.E Vaccine Conjugates Market
11.4.7.3.1 U.A.E Vaccine Conjugates Market by Disease Indication
11.4.7.3.2 U.A.E Vaccine Conjugates Market by Type
11.4.7.3.3 U.A.E Vaccine Conjugates Market by Patient Stage
11.4.7.3.4 U.A.E Vaccine Conjugates Market by Pathogen Type
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Vaccine Conjugates Market Overview
11.5.2 South and Central America Vaccine Conjugates Market Forecasts and Analysis
11.5.3 South and Central America Vaccine Conjugates Market Forecasts and Analysis - By Disease Indication
11.5.4 South and Central America Vaccine Conjugates Market Forecasts and Analysis - By Type
11.5.5 South and Central America Vaccine Conjugates Market Forecasts and Analysis - By Patient Stage
11.5.6 South and Central America Vaccine Conjugates Market Forecasts and Analysis - By Pathogen Type
11.5.7 South and Central America Vaccine Conjugates Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Vaccine Conjugates Market
11.5.7.1.1 Brazil Vaccine Conjugates Market by Disease Indication
11.5.7.1.2 Brazil Vaccine Conjugates Market by Type
11.5.7.1.3 Brazil Vaccine Conjugates Market by Patient Stage
11.5.7.1.4 Brazil Vaccine Conjugates Market by Pathogen Type
11.5.7.2 Argentina Vaccine Conjugates Market
11.5.7.2.1 Argentina Vaccine Conjugates Market by Disease Indication
11.5.7.2.2 Argentina Vaccine Conjugates Market by Type
11.5.7.2.3 Argentina Vaccine Conjugates Market by Patient Stage
11.5.7.2.4 Argentina Vaccine Conjugates Market by Pathogen Type

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. VACCINE CONJUGATES MARKET, KEY COMPANY PROFILES
13.1. BHARAT BIOTECH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIOLOGICAL E
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLAXOSMITHKLINE, PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERCK AND COMPANY
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVARTIS AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PFIZER, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SANOFI PASTEUR
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SERUM INSTITUTE OF INDIA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ASTELLAS PHARMA INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MITSUBISHI TANABE PHARMA CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS